Role of 4-1BB:4-1BB ligand in cancer immunotherapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Link
http://www.nature.com/articles/7700670.pdf
Reference85 articles.
1. Lafferty KJ, Cunningham AJ . A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci. 1975;53:27–42.
2. Carreno BM, Collins M . The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol. 2002;20:29–53.
3. Chambers CA, Allison JP . Costimulatory regulation of T cell function. Curr Opin Cell Biol. 1999;11:203–210.
4. Tai XG, Toyooka K, Yashiro Y, et al. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis. J Immunol. 1997;159:3799–3807.
5. Yashiro Y, Tai XG, Toyo-Oka K, et al. A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other co-stimulatory molecules. Eur J Immunol. 1998;28:926–935.
Cited by 118 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy;Molecules;2024-01-17
2. TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma;iScience;2023-12
3. 4-1BB Targeting Immunotherapy: Mechanism, Antibodies, and Chimeric Antigen Receptor T;Cancer Biotherapy and Radiopharmaceuticals;2023-09-01
4. 4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell;Cellular & Molecular Immunology;2023-06-26
5. Therapeutic strategies to enhance immune response induced by multiple myeloma cells;Frontiers in Immunology;2023-05-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3